Seeking Alpha

Sarepta Therapeutics beats by $0.17, misses on revenues

  • Sarepta Therapeutics (SRPT): Q2 EPS of -$0.46 beats by $0.17.
  • Revenue of $3.0M misses by $2.08M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|